Leukotriene B4/antimicrobial peptide LL‐37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4and resolvin E1 (Q83392510)

From Wikidata

Jump to navigation Jump to search

scientific article published on 09 February 2011

Language	Label	Description	Also known as
English	Leukotriene B4/antimicrobial peptide LL‐37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4and resolvin E1	scientific article published on 09 February 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307335%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307335%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Leukotriene B4/antimicrobial peptide LL‐37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4and resolvin E1 (English)

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

antimicrobial peptide

1 reference

based on heuristic

inferred from title

Catherine Godson

2

object named as

Catherine Godson

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21307335

24 November 2024

author name string

Min Wan

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307335%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Birgitta Agerberth

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307335%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Patrick J. Guiry

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21307335

24 November 2024

Jesper Z. Haeggström

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21307335

24 November 2024

language of work or name

0 references

publication date

9 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307335%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

full work available at URL

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.10-175687

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

https://onlinelibrary.wiley.com/doi/full-xml/10.1096/fj.10-175687

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307335%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307335%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307335%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1697-1705

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307335%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Neutrophils: molecules, functions and pathophysiological aspects

1

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells

2

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

4

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7.

5

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release

6

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37

7

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor.

8

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils

9

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Intracellular receptor for human host defense peptide LL-37 in monocytes

10

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

cPLA2 is phosphorylated and activated by MAP kinase

11

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2

12

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

14

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors

15

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Leukotrienes: underappreciated mediators of innate immune responses

16

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Leukotriene B4 triggers release of the cathelicidin LL-37 from human neutrophils: novel lipid-peptide interactions in innate immune responses.

17

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation

18

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo

19

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells

20

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction

21

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Cutting Edge: Lipoxins Rapidly Stimulate Nonphlogistic Phagocytosis of Apoptotic Neutrophils by Monocyte-Derived Macrophages

22

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis.

23

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing

24

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

25

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Resolvin E1 and protectin D1 activate inflammation-resolution programmes

26

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis

27

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation

28

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation

29

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities

30

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

How should P2X purinoceptors be classified pharmacologically?

31

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Review of epidermal growth factor receptor biology

32

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

The molecular biology of leukocyte chemoattractant receptors

33

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses

34

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

The roles of cathelicidin LL-37 in immune defences and novel clinical applications

35

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Novel pathophysiological role of classical chemotactic peptide receptors and their communications with chemokine receptors.

36

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Differential production of leukotriene B4 or prostaglandin E2 by WKYMVm or serum amyloid A via formyl peptide receptor-like 1.

37

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo

38

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Inverse, protean, and ligand-selective agonism: matters of receptor conformation

39

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Lipoxins inhibit Akt/PKB activation and cell cycle progression in human mesangial cells

40

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

The Lipoxin A4 receptor is coupled to SHP-2 activation: implications for regulation of receptor tyrosine kinases

41

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy

42

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Lipoxin A4Analogues Inhibit Leukocyte Recruitment toPorphyromonas gingivalis: A Role for Cyclooxygenase-2 and Lipoxins in Periodontal Disease†

43

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Lipoxins are potential endogenous antiinflammatory mediators in asthma

44

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma

45

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway

46

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency.

47

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders

48

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis

49

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

The genetic design of signaling cascades to record receptor activation

50

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Leukotriene modifiers as potential therapeutics for cardiovascular disease

51

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability

52

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Involvement of the antimicrobial peptide LL-37 in human atherosclerosis

53

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Colorectal leukotriene B4 synthesis in vitro in inflammatory bowel disease: inhibition by the selective 5-lipoxygenase inhibitor BWA4C

54

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases

55

1 reference

10.1096/FJ.10-175687

https://api.crossref.org/works/10.1096/FJ.10-175687

24 November 2024

Identifiers

10.1096/FJ.10-175687

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307335%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307335%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83392510&oldid=2279635487"